« Back
Home /
Human MKI67 shRNA Plasmid

Human MKI67 shRNA Plasmid

Item no.	abx952907-300
Manufacturer	Abbexa
Amount	300 ug
Category	Oncology Neuroscience Neural Lineage Markers Molecular Targets for Neuroscience Neural Development By Cell Type Blastoma Carcinoma Hematology Lymphoma Cell Biology Cell Status Proliferation Viability By Organ Lung Cancer Bladder Cancer Breast Cancer Testicular & Prostate Cancer Cytoskeleton Markers Nucleic Acids RNA
Type	RNA
Format	Lyophilized
Applications	RNAi
Specific against	Human (Homo sapiens)
Host	E.coli
ECLASS 10.1	32160414
ECLASS 11.0	32160414
UNSPSC	41105324
Available
Manufacturers Category	RNA Oligonucleotides
Description	shRNA Plasmid to inhibit MKI67 expression by RNA interference. This product contains 3 separate slightly different shRNA sequences which knock down human MKI67 gene specifically. Each vial contains 50 μg of lyophilized shRNA.
Dry Ice	No
Buffer	Not applicable.
Gene Symbol	MKI67
Note	This product is for research use only.
Specificity	MKI67 shRNA Plasmid (Human) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA.
Storage	Store lyophilized shRNA plasmid DNA at -20 °C with desiccant. Stable for one year. Once resuspended, store at 4 °C for short term storage or -80 °C for long term storage. Avoid repeated freeze/thaw cycles.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

abx952907-300-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 300 ug

available

Request delivery time